Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation

NCT05717855 is registered in ClinicalTrials.gov with Gaziosmanpasa Research and Education Hospital as lead sponsor.

NCT NCT05717855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05717855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2020
Completion date
April 21, 2021
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

2d ultrasound, cavum septum pellucidum, optic chiasma, septooptic dysplasia, willis polygon